We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
I am CEO & Chief Scientist of IngenoVax and the inventor of the Microbial Mimetics vaccine platform. Based partially on my own battle against cancer, I am profoundly interested in cancer immunotherapy and firmly believe that vaccines will become a major pillar of cancer therapy in the next 5-10 years. My long-term, overarching goal is to clinically develop and commercialize Microbial Mimetics for use in multiple indications, including colorectal, pancreatic, prostate, medullary thyroid, and non-small cell lung cancers, among potential others. I have diverse research background, which spans many fields, including nanomedicine, optics, semiconductor physics, interface chemistry, biomedical sensing, environmental sensing, genomics, and vaccine design. I hold multiple patents and several of my publications have been cited dozens of time. I am a capable and innovative researcher and have gained solid business sense via prior startup- and large corporate-experience.
This speaker's sessions: